Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lisata Therapeutics - 41 Year Stock Price History | LSTA

Historical daily share price chart and data for Lisata Therapeutics since 1984 adjusted for splits and dividends. The latest closing stock price for Lisata Therapeutics as of July 30, 2025 is 2.53.
  • The all-time high Lisata Therapeutics stock closing price was 1000000.00 on November 05, 1984.
  • The Lisata Therapeutics 52-week high stock price is 4.20, which is 66% above the current share price.
  • The Lisata Therapeutics 52-week low stock price is 1.87, which is 26.1% below the current share price.
  • The average Lisata Therapeutics stock price for the last 52 weeks is 2.71.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Lisata Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.5675 3.5700 3.9000 1.9000 2.5300 -15.10%
2024 3.0034 2.7800 3.7000 2.4700 2.9800 9.16%
2023 3.0236 2.5800 4.4000 1.9600 2.7300 7.91%
2022 7.6280 13.3350 15.4500 2.3900 2.5300 -79.96%
2021 22.1608 21.6000 43.3500 12.4500 12.6240 -41.15%
2020 30.8325 37.8405 52.0500 18.1500 21.4500 -43.03%
2019 46.0137 61.2000 79.7250 30.3000 37.6500 -29.49%
2018 72.8386 55.5000 129.6000 52.3500 53.4000 1.42%
2017 62.6894 46.2120 85.9500 39.9000 52.6500 24.03%
2016 81.9788 162.0000 162.0000 41.5500 42.4500 -73.80%
2015 334.4506 559.5000 625.5000 156.0000 162.0000 -71.35%
2014 900.6280 1165.5000 1212.0000 483.0000 565.5000 -44.72%
2013 980.1863 933.0000 1405.5000 750.0000 1023.0000 14.53%
2012 870.2658 795.0000 1200.0000 464.5500 893.2500 17.46%
2011 1734.3452 2100.0000 3015.0000 675.0000 760.5000 -64.04%
2010 2793.8482 2220.0000 5115.0000 1935.0000 2115.0000 -9.03%
2009 2263.1450 900.0000 3787.3500 681.0000 2325.0000 229.79%
2008 1717.8731 2445.0000 2820.0000 630.0000 705.0000 -64.93%
2007 6741.6967 11250.0000 12000.0000 2010.0000 2010.0000 -82.13%
2006 10299.8798 12000.0000 15150.0000 6750.0000 11250.0000 -6.25%
2005 7647.8306 9000.0000 15000.0000 2250.0000 12000.0000 45.45%
2004 15875.0000 27000.0000 33000.0000 6750.0000 8250.0000 -63.33%
2003 20000.0000 10500.0000 46500.0000 4500.0000 22500.0000 275.00%
2002 34723.6919 66000.0000 102000.0000 6000.0000 6000.0000 -90.36%
2001 69154.4118 65625.0000 121500.0000 30000.0000 62250.0000 -17.00%
2000 307512.0211 318750.0000 623438.0000 65625.0000 75000.0000 -73.33%
1999 177758.0814 131250.0000 384375.0000 103125.0000 281250.0000 114.29%
1998 211416.7263 103125.0000 346875.0000 103125.0000 131250.0000 27.27%
1997 101430.2171 23437.5000 159375.0000 23437.5000 103125.0000 340.00%
1996 49089.2857 37500.0000 168750.0000 18750.0000 23437.5000 -37.50%
1995 507695.9055 375000.0000 960938.0000 37500.0000 37500.0000 -90.00%
1994 676839.9486 1000000.0000 1000000.0000 375000.0000 375000.0000 -62.50%
1993 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1992 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1991 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1990 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1989 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1988 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1987 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1986 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1985 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.022B $0.001B
Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $237.532B 17.33
Amgen (AMGN) United States $162.048B 14.52
Gilead Sciences (GILD) United States $142.753B 14.83
Vertex Pharmaceuticals (VRTX) United States $120.479B 0.00
CSL (CSLLY) Australia $84.456B 0.00
GSK (GSK) United Kingdom $79.559B 9.23
Regeneron Pharmaceuticals (REGN) United States $59.876B 14.53
Alnylam Pharmaceuticals (ALNY) United States $44.306B 0.00
Argenex SE (ARGX) Netherlands $36.652B 99.82
Royalty Pharma (RPRX) United States $20.870B 8.82
Insmed (INSM) United States $19.954B 0.00
Biogen (BIIB) United States $18.556B 8.01
Illumina (ILMN) United States $16.884B 32.03
Incyte (INCY) United States $15.011B 19.29
Genmab (GNMSF) Denmark $14.683B 15.02
Genmab (GMAB) Denmark $14.287B 16.02
Moderna (MRNA) United States $12.434B 0.00
QIAGEN (QGEN) Netherlands $11.241B 21.87
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.199B 0.00
Exelixis (EXEL) United States $9.921B 17.89
Bio-Techne Corp (TECH) United States $9.047B 33.75
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.951B 0.00
Exact Sciences (EXAS) United States $8.828B 0.00
Roivant Sciences (ROIV) United Kingdom $7.750B 0.00
Legend Biotech (LEGN) United States $7.426B 0.00
Halozyme Therapeutics (HALO) United States $7.403B 14.17
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.135B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.027B 6.90
Repligen (RGEN) United States $6.902B 75.37
Revolution Medicines (RVMD) United States $6.895B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Anbio Biotechnology (NNNN) Germany $6.043B 0.00
TG Therapeutics (TGTX) United States $5.758B 151.12
Nuvalent (NUVL) United States $5.712B 0.00
Guardant Health (GH) United States $5.599B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.386B 0.00
Axsome Therapeutics (AXSM) United States $4.986B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.981B 0.00
Alkermes (ALKS) Ireland $4.611B 12.81
Merus (MRUS) Netherlands $4.579B 0.00
Telix Pharmaceuticals (TLX) Australia $4.568B 0.00
Abivax SA (ABVX) France $4.496B 0.00
Vaxcyte (PCVX) United States $4.492B 0.00
Avidity Biosciences (RNA) United States $4.445B 0.00
ADMA Biologics Inc (ADMA) United States $4.438B 33.20
Krystal Biotech (KRYS) United States $4.428B 34.12
Cytokinetics (CYTK) United States $4.321B 0.00
Zai Lab (ZLAB) China $4.284B 0.00
PTC Therapeutics (PTCT) United States $4.037B 7.03
Arcellx (ACLX) United States $3.942B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.938B 34.60
Zealand Pharma (ZLDPF) Denmark $3.878B 0.00
Akero Therapeutics (AKRO) United States $3.804B 0.00
Viking Therapeutics (VKTX) United States $3.791B 0.00
Metsera (MTSR) United States $3.717B 0.00
Scholar Rock Holding (SRRK) United States $3.592B 0.00
Protagonist Therapeutics (PTGX) United States $3.385B 72.83
Ascentage Pharma Group - (AAPG) China $3.272B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.230B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.194B 0.00
Kymera Therapeutics (KYMR) United States $2.870B 0.00
Immunovant (IMVT) United States $2.843B 0.00
Alvotech (ALVO) Luxembourg $2.798B 16.00
Ligand Pharmaceuticals (LGND) United States $2.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.532B 0.00
Apellis Pharmaceuticals (APLS) United States $2.388B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.362B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.361B 0.00
ImmunityBio (IBRX) United States $2.260B 0.00
IDEAYA Biosciences (IDYA) United States $2.220B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.194B 751.50
Agios Pharmaceuticals (AGIO) United States $2.174B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.169B 0.00
Twist Bioscience (TWST) United States $2.081B 0.00
Disc Medicine (IRON) United States $2.056B 0.00
CG Oncology (CGON) United States $2.051B 0.00
Vericel (VCEL) United States $2.047B 1355.33
Harmony Biosciences Holdings (HRMY) United States $2.037B 13.54
Beam Therapeutics (BEAM) United States $2.026B 0.00
Mesoblast (MESO) Australia $1.998B 0.00
Denali Therapeutics (DNLI) United States $1.986B 0.00
Amicus Therapeutics (FOLD) United States $1.888B 204.33
Arcutis Biotherapeutics (ARQT) United States $1.738B 0.00
Apogee Therapeutics (APGE) United States $1.732B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.683B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.681B 0.00
Certara (CERT) United States $1.660B 31.00
Sarepta Therapeutics (SRPT) United States $1.646B 0.00
Liquidia Technologies (LQDA) United States $1.634B 0.00
Biohaven (BHVN) United States $1.593B 0.00
Adaptive Biotechnologies (ADPT) United States $1.586B 0.00
Celcuity (CELC) United States $1.568B 0.00
Celldex Therapeutics (CLDX) United States $1.514B 0.00
Edgewise Therapeutics (EWTX) United States $1.497B 0.00
Viridian Therapeutics (VRDN) United States $1.452B 0.00
Janux Therapeutics (JANX) United States $1.434B 0.00
89BIO (ETNB) United States $1.391B 0.00
ANI Pharmaceuticals (ANIP) United States $1.387B 14.29
Travere Therapeutics (TVTX) United States $1.375B 0.00
Jyong Biotech (MENS) Taiwan $1.365B 0.00
AbCellera Biologics (ABCL) Canada $1.364B 0.00
Vera Therapeutics (VERA) United States $1.345B 0.00
Dynavax Technologies (DVAX) United States $1.341B 79.79
Cogent Biosciences (COGT) United States $1.313B 0.00
Intellia Therapeutics (NTLA) United States $1.277B 0.00
WAVE Life Sciences (WVE) Singapore $1.269B 0.00
Cidara Therapeutics (CDTX) United States $1.246B 0.00
NovoCure (NVCR) Jersey $1.226B 0.00
CureVac (CVAC) Germany $1.216B 5.89
GRAIL (GRAL) United States $1.215B 0.00
MannKind (MNKD) United States $1.176B 24.19
Praxis Precision Medicines (PRAX) United States $1.153B 0.00
Novavax (NVAX) United States $1.110B 2.58
Spyre Therapeutics (SYRE) United States $1.042B 0.00
Pharvaris (PHVS) Netherlands $1.035B 0.00
Structure Therapeutics (GPCR) United States $1.022B 0.00
Pacira BioSciences (PCRX) United States $1.008B 9.59
Arcus Biosciences (RCUS) United States $0.999B 0.00
Sana Biotechnology (SANA) United States $0.983B 0.00
MiMedx (MDXG) United States $0.963B 21.73
Anavex Life Sciences (AVXL) United States $0.954B 0.00
Mineralys Therapeutics (MLYS) United States $0.944B 0.00
Immunome (IMNM) United States $0.935B 0.00
Oric Pharmaceuticals (ORIC) United States $0.913B 0.00
Nurix Therapeutics (NRIX) United States $0.908B 0.00
Zymeworks (ZYME) United States $0.902B 0.00
Iovance Biotherapeutics (IOVA) United States $0.892B 0.00
Urogen Pharma (URGN) United States $0.888B 0.00
BGM Group (BGM) China $0.877B 0.00
Trevi Therapeutics (TRVI) United States $0.870B 0.00
LENZ Therapeutics (LENZ) United States $0.866B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.860B 0.00
Nuvation Bio (NUVB) United States $0.820B 0.00
Upstream Bio (UPB) United States $0.817B 0.00
Immatics (IMTX) Germany $0.812B 0.00
UniQure (QURE) Netherlands $0.793B 0.00
Sionna Therapeutics (SION) United States $0.783B 0.00
CorMedix Inc (CRMD) United States $0.783B 52.46
Oculis Holding AG (OCS) Switzerland $0.774B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.754B 0.00
Niagen Bioscience (NAGE) United States $0.751B 105.89
AnaptysBio (ANAB) United States $0.734B 0.00
GH Research (GHRS) Ireland $0.727B 0.00
Vir Biotechnology (VIR) United States $0.724B 0.00
Stoke Therapeutics (STOK) United States $0.703B 16.29
Geron (GERN) United States $0.701B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.696B 0.00
Pharming Group (PHAR) Netherlands $0.691B 0.00
Tango Therapeutics (TNGX) United States $0.683B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.682B 0.00
Gyre Therapeutics (GYRE) United States $0.682B 181.75
Maze Therapeutics (MAZE) United States $0.679B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.677B 0.00
ArriVent BioPharma (AVBP) United States $0.670B 0.00
Dianthus Therapeutics (DNTH) United States $0.669B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Zenas BioPharma (ZBIO) United States $0.659B 0.00
NeoGenomics (NEO) United States $0.659B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.638B 0.00
MeiraGTx Holdings (MGTX) United States $0.634B 0.00
Bicara Therapeutics (BCAX) United States $0.633B 0.00
Arbutus Biopharma (ABUS) United States $0.632B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.608B 0.00
Tyra Biosciences (TYRA) United States $0.592B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.589B 0.00
Keros Therapeutics (KROS) United States $0.588B 0.00
Replimune (REPL) United States $0.587B 0.00
Septerna (SEPN) United States $0.563B 0.00
Fortrea Holdings (FTRE) United States $0.561B 15.50
Arvinas (ARVN) United States $0.553B 0.00
Solid Biosciences (SLDB) United States $0.548B 0.00
Kura Oncology (KURA) United States $0.545B 0.00
Sage Therapeutics (SAGE) United States $0.544B 0.00
Rapport Therapeutics (RAPP) United States $0.541B 0.00
Prime Medicine (PRME) United States $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Rezolute (RZLT) United States $0.523B 0.00
MBX Biosciences (MBX) United States $0.518B 0.00
Terns Pharmaceuticals (TERN) United States $0.516B 0.00
Precigen (PGEN) United States $0.511B 0.00
Cullinan Therapeutics (CGEM) United States $0.482B 0.00
Gossamer Bio (GOSS) United States $0.473B 0.00
Castle Biosciences (CSTL) United States $0.464B 31.53
Cytek Biosciences (CTKB) United States $0.450B 0.00
PureTech Health (PRTC) United States $0.449B 0.00
ATyr Pharma (ATYR) United States $0.440B 0.00
Erasca (ERAS) United States $0.439B 0.00
REGENXBIO (RGNX) United States $0.439B 0.00
Kamada (KMDA) Israel $0.432B 25.93
Compass Therapeutics (CMPX) United States $0.422B 0.00
Tectonic Therapeutic (TECX) United States $0.421B 0.00
Palvella Therapeutics (PVLA) United States $0.414B 0.00
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Kodiak Sciences (KOD) United States $0.385B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Astria Therapeutics (ATXS) United States $0.380B 0.00
Humacyte (HUMA) United States $0.377B 0.00
Myriad Genetics (MYGN) United States $0.373B 0.00
Fulcrum Therapeutics (FULC) United States $0.373B 0.00
Absci (ABSI) United States $0.372B 0.00
Prothena (PRTA) Ireland $0.370B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.369B 0.00
Northwest Biotherapeutics (NWBO) United States $0.352B 0.00
Olema Pharmaceuticals (OLMA) United States $0.349B 0.00
Abeona Therapeutics (ABEO) United States $0.348B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.344B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.343B 69.75
Verastem (VSTM) United States $0.342B 0.00
Neumora Therapeutics (NMRA) United States $0.336B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.335B 0.00
Cartesian Therapeutics (RNAC) United States $0.334B 0.00
Inhibrx Biosciences (INBX) United States $0.333B 0.20
Aura Biosciences (AURA) United States $0.331B 0.00
Emergent Biosolutions (EBS) United States $0.329B 0.00
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
Ocugen (OCGN) United States $0.312B 0.00
Neurogene (NGNE) United States $0.312B 0.00
Amarin (AMRN) Ireland $0.310B 0.00
Inventiva S.A (IVA) France $0.308B 0.00
XOMA Royalty (XOMA) United States $0.307B 0.00
Foghorn Therapeutics (FHTX) United States $0.304B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.299B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.292B 0.00
Annexon (ANNX) United States $0.284B 0.00
Allogene Therapeutics (ALLO) United States $0.282B 0.00
ScPharmaceuticals (SCPH) United States $0.277B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.277B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.277B 0.00
Vor Biopharma (VOR) $0.276B 0.00
Aardvark Therapeutics (AARD) United States $0.275B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.275B 0.00
Sagimet Biosciences (SGMT) United States $0.273B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.264B 0.00
Lifecore Biomedical (LFCR) United States $0.263B 0.00
Monopar Therapeutics (MNPR) United States $0.261B 0.00
Alpha Teknova (TKNO) United States $0.259B 0.00
Prima BioMed (IMMP) Australia $0.258B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Entrada Therapeutics (TRDA) United States $0.252B 8.20
Crescent Biopharma (CBIO) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.243B 0.00
Tvardi Therapeutics (TVRD) United States $0.240B 0.00
Bright Minds Biosciences (DRUG) United States $0.238B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Codexis (CDXS) United States $0.231B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
MaxCyte (MXCT) United States $0.225B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.224B 0.00
Alumis (ALMS) United States $0.223B 0.00
AC Immune (ACIU) Switzerland $0.219B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Editas Medicine (EDIT) United States $0.211B 0.00
CARGO Therapeutics (CRGX) United States $0.206B 0.00
GENFIT S.A (GNFT) France $0.199B 0.00
Innate Pharma S.A (IPHA) France $0.195B 0.00
Voyager Therapeutics (VYGR) United States $0.191B 0.00
Ventyx Biosciences (VTYX) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.191B 0.00
Caribou Biosciences (CRBU) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.189B 0.00
Semper Paratus Acquisition (TVGN) United States $0.188B 0.00
Rapt Therapeutics (RAPT) United States $0.187B 0.00
CytomX Therapeutics (CTMX) United States $0.187B 4.83
EnGene Holdings (ENGN) Canada $0.179B 0.00
Instil Bio (TIL) United States $0.177B 0.00
Citius Oncology (CTOR) United States $0.169B 0.00
Cardiff Oncology (CRDF) United States $0.166B 0.00
SELLAS Life Sciences (SLS) United States $0.166B 0.00
I-Mab (IMAB) United States $0.165B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.163B 0.00
Kyverna Therapeutics (KYTX) United States $0.163B 0.00
Agenus (AGEN) United States $0.162B 0.00
Black Diamond Therapeutics (BDTX) United States $0.160B 47.00
Alector (ALEC) United States $0.160B 0.00
Elicio Therapeutics (ELTX) United States $0.159B 0.00
BioAge Labs (BIOA) United States $0.158B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.157B 4.10
Contineum Therapeutics (CTNM) United States $0.155B 0.00
Nkarta (NKTX) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
C4 Therapeutics (CCCC) United States $0.153B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Actuate Therapeutics (ACTU) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.149B 0.00
Cellectis S.A (CLLS) France $0.148B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
IO Biotech (IOBT) Denmark $0.140B 0.00
Genelux (GNLX) United States $0.133B 0.00
Fate Therapeutics (FATE) United States $0.131B 0.00
Immuneering (IMRX) United States $0.131B 0.00
23andMe Holding (MEHCQ) United States $0.129B 0.00
Compugen (CGEN) Israel $0.129B 0.00
Seer (SEER) United States $0.128B 0.00
Sangamo Therapeutics (SGMO) United States $0.127B 0.00
Seres Therapeutics (MCRB) United States $0.126B 0.00
BioHarvest Sciences (BHST) Canada $0.122B 0.00
Spero Therapeutics (SPRO) United States $0.122B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.120B 0.00
Tenaya Therapeutics (TNYA) United States $0.119B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.118B 0.00
Connect Biopharma Holdings (CNTB) United States $0.117B 0.00
Anika Therapeutics (ANIK) United States $0.116B 0.00
TuHURA Biosciences (HURA) United States $0.113B 0.00
Coherus Oncology (CHRS) United States $0.112B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.105B 0.00
Climb Bio (CLYM) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.099B 0.00
Zura Bio (ZURA) United States $0.098B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Adagene (ADAG) China $0.095B 0.00
OKYO Pharma (OKYO) $0.094B 0.00
Pliant Therapeutics (PLRX) United States $0.093B 0.00
Immunic (IMUX) United States $0.092B 0.00
Entera Bio (ENTX) Israel $0.092B 0.00
Invivyd (IVVD) United States $0.090B 0.00
Scilex Holding (SCLX) United States $0.090B 0.00
Quince Therapeutics (QNCX) United States $0.088B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.088B 0.00
XBiotech (XBIT) United States $0.088B 0.00
VistaGen Therapeutics (VTGN) United States $0.086B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
Whitehawk Therapeutics (WHWK) United States $0.084B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
Elutia (ELUT) United States $0.081B 0.00
Celularity (CELU) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
CervoMed (CRVO) United States $0.074B 0.00
Artiva Biotherapeutics (ARTV) United States $0.073B 0.00
Atara Biotherapeutics (ATRA) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Oncobiologics (OTLK) United States $0.069B 0.00
Forte Biosciences (FBRX) United States $0.067B 0.00
MediciNova (MNOV) United States $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.066B 0.00
MiNK Therapeutics (INKT) United States $0.066B 0.00
Opus Genetics (IRD) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.065B 0.00
INmune Bio (INMB) United States $0.063B 0.00
Cue Biopharma (CUE) United States $0.061B 0.00
Applied Therapeutics (APLT) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Earth Science Tech (ETST) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.053B 0.00
Adlai Nortye (ANL) Cayman Islands $0.052B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
PDS Biotechnology (PDSB) United States $0.050B 0.00
Adverum Biotechnologies (ADVM) United States $0.050B 0.00
ABVC BioPharma (ABVC) United States $0.049B 0.00
Aligos Therapeutics (ALGS) United States $0.048B 0.00
Renovaro (RENB) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
KALA BIO (KALA) United States $0.046B 0.00
Alterity Therapeutics - (ATHE) Australia $0.046B 0.00
PepGen (PEPG) United States $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
RenovoRx (RNXT) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Exicure (XCUR) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Cognition Therapeutics (CGTX) United States $0.039B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.038B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Ovid Therapeutics (OVID) United States $0.036B 0.00
Clearside Biomedical (CLSD) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Medicus Pharma (MDCX) United States $0.034B 0.00
Mersana Therapeutics (MRSN) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
ALX Oncology Holdings (ALXO) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.030B 0.00
Clene (CLNN) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Femasys (FEMY) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.024B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Aytu BioPharma (AYTU) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.021B 0.00
180 Life Sciences (ATNF) United States $0.021B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.020B 0.00
Rallybio (RLYB) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.020B 0.00
Passage Bio (PASG) United States $0.019B 0.00
Abpro Holdings (ABP) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Curis (CRIS) United States $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
MetaVia (MTVA) United States $0.012B 0.00
IBio (IBIO) United States $0.011B 0.00
Advanced Biomed (ADVB) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Synaptogenix (TAOX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
LakeShore Biopharma (LSB) China $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Apollomics (APLM) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00